Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 591 entries
View as:

Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00792142 Org: User:
Start: 01/16/08 End: 04/21/14 Due: 04/21/15

Perception of Cure Among Patients With Metastatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04820894 Org: User:
Start: 10/30/21 End: 01/05/22 Due: 01/05/23

Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04227028 Org: User:
Start: 03/09/20 End: 06/01/25 Due: 06/01/26

Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT04212416 Org: User:
Start: 05/12/20 End: 06/12/25 Due: 06/12/26

Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT02500849 Org: User:
Start: 03/10/16 End: 06/13/25 Due: 06/13/26

Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03467386 Org: User:
Start: 03/19/18 End: 04/06/26 Due: 04/06/27

A Multidisciplinary Approach to Improve the Health of Older Adults With Blood Cancers After Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT04914338 Org: User:
Start: 06/03/21 End: 02/03/26 Due: 02/03/27

Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04428905 Org: User:
Start: 07/11/20 End: 03/31/26 Due: 03/31/27

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04508790 Org: User:
Start: 11/27/20 End: 02/14/27 Due: 02/14/28

Laparoscopic Surgery or Robotic-Assisted Laparoscopic Surgery in Treating Patients With Rectal Cancer That Can Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01196000 Org: User:
Start: 12/31/11 End: - Due: -

Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01807065 Org: User:
Start: 06/07/13 End: 12/31/19 Due: 12/31/20

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002931 Org: User:
Start: 02/28/97 End: 12/31/14 Due: 12/31/15

Optical Coherence Tomography in Tissue Samples From Women Undergoing Mastectomy for the Treatment or Prevention of Breast Ductal Intraepithelial Neoplasia

Phase: N/A Priority: Normal
NCT ID: NCT00807404 Org: User:
Start: 11/30/06 End: 03/31/09 Due: 03/31/10

Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05203627 Org: User:
Start: 01/21/20 End: 06/30/25 Due: 06/30/26

Telehealth Exercise Intervention to Improve Physical Function and Frailty in Multiple Myeloma Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05142371 Org: User:
Start: 10/06/21 End: 03/28/25 Due: 03/28/26

Pancreatic Cancer Detection Consortium

Phase: N/A Priority: Normal
NCT ID: NCT06388967 Org: User:
Start: 03/15/23 End: 11/21/25 Due: 11/21/26

Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants

Phase: N/A Priority: Normal
NCT ID: NCT05364762 Org: User:
Start: 11/23/22 End: 05/22/26 Due: 05/22/27

A Standardized Nursing Intervention Protocol for HCT Patients

Phase: N/A Priority: Normal
NCT ID: NCT00951626 Org: User:
Start: 09/30/05 End: 09/30/11 Due: 09/30/12

Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02226276 Org: User:
Start: 01/07/15 End: 10/30/25 Due: 10/30/26

Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00005839 Org: User:
Start: 08/31/00 End: 06/30/04 Due: 06/30/05

LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04560972 Org: User:
Start: 05/28/21 End: 03/09/26 Due: 03/09/27

Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2

Phase: N/A Priority: Normal
NCT ID: NCT01082926 Org: User:
Start: 05/31/10 End: 09/30/13 Due: 09/30/14

Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05138991 Org: User:
Start: 06/22/22 End: 06/30/25 Due: 06/30/26

Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00530634 Org: User:
Start: 08/31/99 End: 06/30/13 Due: 06/30/14

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02948283 Org: User:
Start: 09/05/17 End: 12/01/17 Due: 12/01/18